Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area

BACKGROUND: We evaluated the efficacy of the Siemens SARS-CoV-2 Total Antibody assay (CV2T) and IgG assay (CV2G) that can detect antibodies against the receptor binding domain of S antigen in patients with COVID-19 in a Tokyo metropolitan area. METHODS: Sensitivity and antibody levels were examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Igawa, Gene, Yamamoto, Takamasa, Baba, Yuna, Shinozuka, Konomi, Yuri, Maiko, Wakita, Mitsuru, Misawa, Shigeki, Miida, Takashi, Ai, Tomohiko, Tabe, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592641/
https://www.ncbi.nlm.nih.gov/pubmed/34805572
http://dx.doi.org/10.1016/j.heliyon.2021.e08393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592641/
https://www.ncbi.nlm.nih.gov/pubmed/34805572
http://dx.doi.org/10.1016/j.heliyon.2021.e08393

Ejemplares similares